{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:43:08Z","timestamp":1707525788628},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,23]]},"DOI":"10.7759\/cureus.52810","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T23:39:35Z","timestamp":1706053175000},"source":"Crossref","is-referenced-by-count":0,"title":["Vitiligo and Alopecia Areata After Donor Lymphocyte Infusions in a Child With Relapsed Acute Myeloid Leukemia"],"prefix":"10.7759","author":[{"given":"Fan-Yu","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Lun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chi","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Yen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang-Her","family":"Jaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.12.025","article-title":"Vitiligo following autologous hematopoietic stem cell transplantation","volume":"20","author":"Nguyen J","year":"2020","unstructured":"Nguyen J, Singh N, Afifi S, Giralt S, Lacouture ME, Busam KJ, Hassoun H. Vitiligo following autologous hematopoietic stem cell transplantation. Clin Lymphoma Myeloma Leuk. 2020, 20:e171-3. 10.1016\/j.clml.2019.12.025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29307","article-title":"Vitiligo: a narrative review","volume":"14","author":"Joge RR","year":"2022","unstructured":"Joge RR, Kathane PU, Joshi SH. Vitiligo: a narrative review. Cureus. 2022, 14:e29307. 10.7759\/cureus.29307","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3325\/cmj.2016.57.229","article-title":"High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease","volume":"57","author":"\u010ceovi\u0107 R","year":"2016","unstructured":"\u010ceovi\u0107 R, Desnica L, Pulani\u0107 D, et al.. High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease. Croat Med J. 2016, 57:229-38. 10.3325\/cmj.2016.57.229","journal-title":"Croat Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.1550","article-title":"Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease","volume":"151","author":"Zuo RC","year":"2015","unstructured":"Zuo RC, Naik HB, Steinberg SM, et al.. Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease. JAMA Dermatol. 2015, 151:23-32. 10.1001\/jamadermatol.2014.1550","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.914898","article-title":"Perspectives of new advances in the pathogenesis of vitiligo: from oxidative stress to autoimmunity","volume":"25","author":"Wang Y","year":"2019","unstructured":"Wang Y, Li S, Li C. Perspectives of new advances in the pathogenesis of vitiligo: from oxidative stress to autoimmunity. Med Sci Monit. 2019, 25:1017-23. 10.12659\/MSM.914898","journal-title":"Med Sci Monit"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15121","article-title":"Vitiligo-like manifestations of graft-versus-host disease in a pediatric population","volume":"40","author":"Dai J","year":"2023","unstructured":"Dai J, Hight RS, Grullon K, Xiao TL, Stein SL. Vitiligo-like manifestations of graft-versus-host disease in a pediatric population. Pediatr Dermatol. 2023, 40:157-61. 10.1111\/pde.15121","journal-title":"Pediatr Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0626-x","article-title":"Vitiligo following stem-cell transplant","volume":"55","author":"Totani A","year":"2020","unstructured":"Totani A, Amin H, Bacchi S, Lewis I. Vitiligo following stem-cell transplant. Bone Marrow Transplant. 2020, 55:332-40. 10.1038\/s41409-019-0626-x","journal-title":"Bone Marrow Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.04.005","article-title":"Immune-mediated complications after hematopoietic stem cell transplantation","volume":"22","author":"Li Z","year":"2016","unstructured":"Li Z, Rubinstein SM, Thota R, et al.. Immune-mediated complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016, 22:1368-75. 10.1016\/j.bbmt.2016.04.005","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.08.011","article-title":"MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota","volume":"51","author":"Koyama M","year":"2019","unstructured":"Koyama M, Mukhopadhyay P, Schuster IS, et al.. MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota. Immunity. 2019, 51:885-898.e7. 10.1016\/j.immuni.2019.08.011","journal-title":"Immunity"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0183-8","article-title":"CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide","volume":"53","author":"Mussetti A","year":"2018","unstructured":"Mussetti A, De Philippis C, Carniti C, et al.. CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide. Bone Marrow Transplant. 2018, 53:1522-31. 10.1038\/s41409-018-0183-8","journal-title":"Bone Marrow Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.790299","article-title":"Optimization of donor lymphocyte infusion for AML relapse after allo-HCT in the era of new drugs and cell engineering","volume":"11","author":"Ye Y","year":"2021","unstructured":"Ye Y, Yang L, Yuan X, Huang H, Luo Y. Optimization of donor lymphocyte infusion for AML relapse after allo-HCT in the era of new drugs and cell engineering. Front Oncol. 2021, 11:790299. 10.3389\/fonc.2021.790299","journal-title":"Front Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.219790","article-title":"Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT","volume":"105","author":"Dholaria B","year":"2020","unstructured":"Dholaria B, Savani BN, Labopin M, et al.. Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT. Haematologica. 2020, 105:47-58. 10.3324\/haematol.2019.219790","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00777","article-title":"Can graft vs. leukemia effect be uncoupled from graft vs. host disease? An examination of proportions","volume":"11","author":"Krieger E","year":"2020","unstructured":"Krieger E, Toor AA. Can graft vs. leukemia effect be uncoupled from graft vs. host disease? An examination of proportions. Front Immunol. 2020, 11:777. 10.3389\/fimmu.2020.00777","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-102119-073227","article-title":"Current concepts and advances in graft-versus-host disease Immunology","volume":"39","author":"Hill GR","year":"2021","unstructured":"Hill GR, Betts BC, Tkachev V, Kean LS, Blazar BR. Current concepts and advances in graft-versus-host disease Immunology. Annu Rev Immunol. 2021, 39:19-49. 10.1146\/annurev-immunol-102119-073227","journal-title":"Annu Rev Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S420342","article-title":"Generalized vitiligo after stem cell transplantation: a case report","volume":"16","author":"Wang Y","year":"2023","unstructured":"Wang Y, Hu W, Lin F, Xu AE. Generalized vitiligo after stem cell transplantation: a case report. Clin Cosmet Investig Dermatol. 2023, 16:1945-8. 10.2147\/CCID.S420342","journal-title":"Clin Cosmet Investig Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/223680-vitiligo-and-alopecia-areata-after-donor-lymphocyte-infusions-in-a-child-with-relapsed-acute-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:55Z","timestamp":1707509635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/223680-vitiligo-and-alopecia-areata-after-donor-lymphocyte-infusions-in-a-child-with-relapsed-acute-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.52810","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,23]]}}}